JPH07502523A - 抗レトロウイルス作用を有する化合物としての複素環置換ベンジルアミン誘導体 - Google Patents

抗レトロウイルス作用を有する化合物としての複素環置換ベンジルアミン誘導体

Info

Publication number
JPH07502523A
JPH07502523A JP5511436A JP51143693A JPH07502523A JP H07502523 A JPH07502523 A JP H07502523A JP 5511436 A JP5511436 A JP 5511436A JP 51143693 A JP51143693 A JP 51143693A JP H07502523 A JPH07502523 A JP H07502523A
Authority
JP
Japan
Prior art keywords
group
formula
hydrogen
tables
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5511436A
Other languages
English (en)
Japanese (ja)
Inventor
ジヤンセン，マルセル・アウグスト・コンスタント
バン・ダエレ，ジヨルジユ・アンリ・ポール
ボスマンス，ジヤン−ポール・ルネ・マリー・アンドレ
フエルドンク，マルク・グスターフ・セリネ
ジヤンセン，パウル・アドリアーン・ジヤン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of JPH07502523A publication Critical patent/JPH07502523A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
JP5511436A 1991-12-30 1992-12-22 抗レトロウイルス作用を有する化合物としての複素環置換ベンジルアミン誘導体 Pending JPH07502523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91203431 1991-12-30
EP91203431.1 1991-12-30
PCT/EP1992/002993 WO1993013069A1 (en) 1991-12-30 1992-12-22 Heterocycle-substituted benzylamine derivatives as antiretroviral compounds

Publications (1)

Publication Number Publication Date
JPH07502523A true JPH07502523A (ja) 1995-03-16

Family

ID=8208119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5511436A Pending JPH07502523A (ja) 1991-12-30 1992-12-22 抗レトロウイルス作用を有する化合物としての複素環置換ベンジルアミン誘導体

Country Status (16)

Country Link
US (5) US5480997A (enExample)
EP (1) EP0620811A1 (enExample)
JP (1) JPH07502523A (enExample)
CN (1) CN1034074C (enExample)
AP (1) AP392A (enExample)
AU (1) AU658260B2 (enExample)
CA (1) CA2125675A1 (enExample)
FI (1) FI943119L (enExample)
HU (1) HUT70515A (enExample)
IL (1) IL104257A (enExample)
MX (1) MX9207619A (enExample)
NO (1) NO942480D0 (enExample)
PH (1) PH30258A (enExample)
TW (1) TW221688B (enExample)
WO (1) WO1993013069A1 (enExample)
ZA (1) ZA9210078B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587387A (en) * 1991-12-30 1996-12-24 Janssen Pharmaceutica N.V. Heterocycle-substituted benzenemethanamine derivatives
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274190A (en) * 1966-09-20 Hydroxyphenethyl-amino-s-triazine
ES368093A1 (es) * 1968-07-16 1971-07-16 Degussa Procedimiento para la preparacion de bencilaminas n-hetero-ciclicamente sustituidas.
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
AU7168091A (en) * 1989-12-22 1991-07-24 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
WO1991009849A1 (en) * 1989-12-28 1991-07-11 The Upjohn Company Diaromatic substituted anti-aids compounds

Also Published As

Publication number Publication date
TW221688B (enExample) 1994-03-11
ZA9210078B (en) 1994-06-29
FI943119A7 (fi) 1994-06-29
US5550135A (en) 1996-08-27
AP9200468A0 (en) 1993-01-31
FI943119A0 (fi) 1994-06-29
NO942480L (no) 1994-06-30
US5480997A (en) 1996-01-02
MX9207619A (es) 1993-06-01
US5541215A (en) 1996-07-30
WO1993013069A1 (en) 1993-07-08
CA2125675A1 (en) 1993-07-08
HUT70515A (en) 1995-10-30
US5552430A (en) 1996-09-03
CN1073942A (zh) 1993-07-07
EP0620811A1 (en) 1994-10-26
US5604230A (en) 1997-02-18
IL104257A (en) 1996-12-05
AP392A (en) 1995-08-03
IL104257A0 (en) 1993-05-13
AU658260B2 (en) 1995-04-06
PH30258A (en) 1997-02-05
NO942480D0 (no) 1994-06-30
CN1034074C (zh) 1997-02-19
FI943119L (fi) 1994-06-29
HU9401380D0 (en) 1994-08-29
AU3258093A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
JP4742026B2 (ja) ロフルミラストの新規の製造方法
DE602004011348T2 (de) Indanderivate als muscarinrezeptoragonisten
JPH07502742A (ja) Ｐａｆ−レセプタ拮抗剤としてのアミノ酸誘導体
EP3480199B1 (en) Imidazopyridinamine phenyl derivative and use thereof
JPH05508845A (ja) 選択的ロイコトリエンｂ４拮抗活性を示す置換２環式ビス―アリール組成物、それらの調製および医薬組成物における使用
JPH03176469A (ja) イソインドロン誘導体
JPH07500599A (ja) ホスホジエステラーゼ阻害剤としての１，３−ジヒドロ−２Ｈ−イミダゾ（４，５−ｂ）キノリン−２−オン誘導体類
EA002113B1 (ru) Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно)
WO2000075113A1 (en) Novel heterocyclic carboxamide derivatives
JP7661361B2 (ja) Ｉｌ－１７のモジュレーターとしてのイミダゾピリミジン
JPH05507931A (ja) Ｈｉｖ―阻害性ベンゼンアセトアミド誘導体
CN105473573A (zh) 用作激酶抑制剂的咔唑甲酰胺化合物
JPH07502524A (ja) α−置換ベンゼンメタナミン誘導体
JPH07502523A (ja) 抗レトロウイルス作用を有する化合物としての複素環置換ベンジルアミン誘導体
JPH05112562A (ja) ３−（１，２−ベンズイソキサゾール−３−イル）−４−ピリジンアミンおよび誘導体
JPH02243673A (ja) シクロプロピル置換アゾリルメチルカルビノール誘導体、その製造方法及び医薬としてのその用途
JP2002516907A (ja) 酸化窒素合成酵素阻害剤として縮合環置換基を含有する２−アミノピリジン
CN119522215A (zh) Tead抑制剂和使用方法
US5587387A (en) Heterocycle-substituted benzenemethanamine derivatives
JPH07503002A (ja) Ｎｍｄａアンタゴニストとしてのニトロキノロン誘導体
IL99434A (en) 3-(1h-indazol-3-yl)-4-pyridinamines a process for their preparation and pharmaceutical compositions containing them
JPH05500053A (ja) 抗ウイルス性テトラヒドロイミダゾ［１，４］ベンゾジアゼピン類
JPH07501329A (ja) 血管拡張活性を有するニトロ化合物
JPWO2021055589A5 (enExample)
JPH06509086A (ja) 新規な２−アミノナフチリジン誘導体、それの製造および使用